Justin Kosar
Prince Albert, SK, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Retrospective analysis and clinical performance of BD MAX enteric pathogen testing with a focus on reliable identification of vibrio species in stool samples.
Journal: Diagnostic microbiology and infectious disease
Published: December 13, 2024
Ceftolozane/Tazobactam treatment for patients with hospital-acquired and ventilatory-associated bacterial pneumonia in Canada in 2022-2024: results from the CLEAR registry.
Journal: Expert review of anti-infective therapy
Published: September 26, 2024
How is ceftobiprole used in Canada: the CLEAR study final results.
Journal: Expert review of anti-infective therapy
Published: July 15, 2024
Real-life experience with IV fosfomycin in Canada: Results from the Canadian LEadership on Antimicrobial Real-life usage (CLEAR) registry.
Journal: Journal of global antimicrobial resistance
Published: November 27, 2022
The 2018 Global Point Prevalence Survey of antimicrobial consumption and resistance in 47 Canadian hospitals: a cross-sectional survey.
Journal: CMAJ open
Published: December 22, 2021
Real-life experience with ceftolozane/tazobactam in Canada: results from the CLEAR (Canadian LEadership on Antimicrobial Real-life usage) registry.
Journal: Journal of global antimicrobial resistance
Published: January 12, 2021
Real-life experience with ceftobiprole in Canada: Results from the CLEAR (CanadianLEadership onAntimicrobialReal-life usage) registry.
Journal: Journal of global antimicrobial resistance
Published: January 11, 2021
Antimicrobial use among adult inpatients at hospital sites within the Canadian Nosocomial Infection Surveillance Program: 2009 to 2016.
Journal: Antimicrobial resistance and infection control
Published: October 25, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026